Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,644 | 1,834 | 12,584 | 9,906 | 23,645 |
| Other current assets | 0 | 0 | 499 | 759 | 1,123 |
| TOTAL | $16,526 | $2,374 | $13,083 | $10,665 | $24,767 |
| Non-Current Assets | |||||
| PPE Net | 63 | 6 | 838 | 1,098 | 1,295 |
| Intangibles | 7,647 | 272 | 0 | 0 | 0 |
| Other Non-Current Assets | 132 | 121 | 496 | 39 | 178 |
| TOTAL | $7,843 | $399 | $1,334 | $1,137 | $1,473 |
| Total Assets | $24,369 | $2,773 | $14,417 | $11,802 | $26,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 96 | 383 | 740 | 703 | 696 |
| Accrued Expenses | 1,937 | 438 | 1,008 | 1,050 | 1,233 |
| TOTAL | $2,033 | $821 | $4,801 | $3,132 | $3,325 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 2,905 | 1,231 | 1,395 |
| Other Non-Current Liabilities | 0 | 12,136 | 0 | 0 | 0 |
| TOTAL | $N/A | $12,136 | $N/A | $1,231 | $2,338 |
| Total Liabilities | $2,033 | $12,958 | $4,801 | $4,363 | $5,663 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,497 | 740 | 675 | 341 | 333 |
| Common Shares | 75 | 25 | 70 | 35 | 276 |
| Retained earnings | -25,552 | -11,357 | -153,340 | -141,320 | -126,268 |
| TOTAL | $22,336 | $-10,185 | $9,615 | $7,439 | $20,577 |
| Total Liabilities And Equity | $24,369 | $2,773 | $14,417 | $11,802 | $26,240 |